Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

New technologies and care plans aim to enhance treatment options for patients in Mitchell and the surrounding area ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

The 32nd international conference of the Indian Association of Palliative Care (IAPC) commenced at the All India Institute of Medical Sciences (AIIMS) here on Friday, officials said. Jammu and Kashmir ...

Budget 2025 proposes to transform cancer care, medical education, and global healthcare leadership: Experts: Our Bureau, Mumbai Saturday, February 1, 2025, 15:40 Hrs [IST] The Uni ...

According to FAIR Health, a cost estimation tool that uses claims data, an uninsured patient in the Scranton area could expect to be charged $1,183 for an IUD insertion done at an ambulatory surgery ...

Who was on the plane that crashed outside D.C.? How many people died in the plane crash? Here's what we know after the plane ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...